Rejuvenate Biomed are ready to take their first Longevity therapy into clinical trials: Invest, buy, or both?
It’s time to have your say on Rejuvenate Biomed.
We like Longevity therapies derived from existing ‘off-patent’ drugs and this is what Rejuvenate Biomed are doing; they’re de-risked, unencumbered by licensing complexities and have great results from their research … but that’s just our opinion – you’re the ones with the investment and buying potential: What do you think?
- Watch the video pitch and investor questions;
- Check-out the slide deck;
- Take the 30 secs survey and see what others think!
The video pitch and investor questions:
The slide deck:Rejuvenate Biomed Pitch Deck Longevity.Technology
The 30-second survey (with live results):
Would you like to know more?
We’re happy to pass along your comments and questions to the Rejuvenate Biomed team: you can email us via this link. Thanks.
Thanks for engaging – we have regular Startup Showcases coming-up: stay tuned!